New resource for selecting best treatment path for young children with cancerous tumors published by NCCN

March 8, 2024
New NCCN Guidelines for Neuroblastoma address the importance and impact of risk stratification for treating one of the more common types of pediatric solid tumors; includes vanguard treatment recommendations involving multimodality treatment for high-risk disease.

The National Comprehensive Cancer Network (NCCN) published a set of treatment recommendations pertaining to neuroblastoma.

There are now 87 different NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), covering nearly every type of cancer, plus screening, prevention, and supportive care. The NCCN Guidelines for Neuroblastoma are the 6th to focus specifically on treating pediatric cancer.     

NCCN also publishes NCCN Guidelines for Adolescent and Young Adult Oncology, which provide treatment advice geared toward younger populations across all cancer types. There are separate NCCN Guidelines for Survivorship that include additional information on mitigating the long-term impact of treatment.

NCCN release on Newswise

ID 102428331 © Jakub Jirsak | Dreamstime.com
dreamstime_xxl_102428331
ID 177400875 © Elmer Grubbs | Dreamstime.com
dreamstime_xxl_177400875
ID 90790743 © Rido | Dreamstime.com
dreamstime_xxl_90790743_1